$JNJ News Billionaire Stan Druckenmiller's recent moves

New Post Public Reply Private Reply Replies (0) Message Board

Feb 26, 2014 at 11:26 AM

$JNJ News

Billionaire Stan Druckenmiller's recent moves 11:50 a.m. Feb. 24, 2014 - Insider Monkey
You'd have to be a dope to buy marijuana stocks 1:36 p.m. Feb. 13, 2014 - blogs.marketwatch.com
FDA approval of leukemia treatment boosts shares of Pharmacyclics 1:57 p.m. Feb. 12, 2014 - blogs.marketwatch.com
Goldman: The 4 biggest themes of earnings season 8:06 a.m. Feb. 12, 2014 - blogs.marketwatch.com
10 stocks to beat a declining market 3:01 p.m. Feb. 7, 2014 - Mark Hulbert
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
CVS move won’t slow e-cigarette sales 4:42 p.m. Feb. 5, 2014 - Jonnelle Marte
Newscast: Stocks mixed to start short week 6:32 p.m. Jan. 21, 2014 - MarketWatch
U.S. stocks close higher; earnings misses drag on Dow 4:51 p.m. Jan. 21, 2014 - Anora Mahmudova
Newscast: Stocks open week mixed 4:32 p.m. Jan. 21, 2014 - MarketWatch
Nasdaq nabs 13-year high, but Dow slips: stock market live blog recap 4:05 p.m. Jan. 21, 2014 - blogs.marketwatch.com
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Johnson & Johnson shares take a hit on full-year outlook 11:27 a.m. Jan. 21, 2014 - blogs.marketwatch.com
Newscast: Demand soars for humanely-raised pork 10:00 a.m. Jan. 21, 2014 - MarketWatch
Johnson & Johnson’s profit jumps 37% 9:49 a.m. Jan. 21, 2014 - Tess Stynes
Stock futures rise after China’s cash injections 9:32 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson sees 2014 EPS of $5.75 to $5.85 7:51 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS excluding items $1.24 7:50 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 sales up 4.5% to $18.4B 7:49 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS $1.23 vs. 91 cents 7:48 a.m. Jan. 21, 2014 - Barbara Kollmeyer

Risk And Reward Analysis Of Apple's Stock 49 min ago - Seeking Alpha
Are High-Yield Equities Riskier Than Dividend Growth Stocks? 9:43 a.m. Today - Seeking Alpha
Anika Arthritis Treatment Approval Brings All-Time Highs, Maybe More to Come 9:16 a.m. Today - 247WallSt.com
Anika's Osteoarthritis Treatment Wins FDA Approval 5:45 p.m. Feb. 25, 2014 - WSJ.com
3 Dividend Stocks For Retirement 4:57 p.m. Feb. 25, 2014 - Seeking Alpha
Target's Valuation Largely Hits the Mark 4:12 p.m. Feb. 25, 2014 - WSJ.com
Study: Tylenol in Pregnancy Linked to ADHD 7:56 a.m. Feb. 25, 2014 - InvestorPlace.com
The Ultimate Status Symbol: Freedom 5:56 a.m. Feb. 25, 2014 - GuruFocus.com
Colgate-Palmolive Operates In A Favorable Industry 5:49 a.m. Feb. 25, 2014 - Seeking Alpha
5 Biotech Stocks That Are Buyout Candidates 3:48 a.m. Feb. 25, 2014 - InvestorPlace.com
Pharmacyclics Attains 52-Week High - Analyst Blog 5:00 p.m. Feb. 24, 2014 - Zacks.com
Dow Today: Visa (V) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 4:30 p.m. Feb. 24, 2014 - TheStreet.com
One Put, One Call Option To Know About For Johnson & Johnson 12:17 p.m. Feb. 24, 2014 - TheStreet.com
Interesting JNJ Put And Call Options For October 18th 11:51 a.m. Feb. 24, 2014 - TheStreet.com
Allergan: 8 Different Insiders Have Sold Shares This Month 11:03 a.m. Feb. 24, 2014 - Seeking Alpha
Following The Latest In Alzheimer's Research As An Investor 10:12 a.m. Feb. 24, 2014 - Seeking Alpha
P&G Seeks to Sell Health-Care Operator 9:41 a.m. Feb. 24, 2014 - WSJ.com
Blood Glucose Self-Monitoring Market Not As Bright As It Seems 8:06 p.m. Feb. 23, 2014 - Seeking Alpha
Hospitals Focus on the Supply Chain 5:03 p.m. Feb. 23, 2014 - WSJ.com
10-K: JOHNSON & JOHNSON 2:32 p.m. Feb. 21, 2014 - Edgar Online - (EDG = 10Q, 10K)

Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation 6:26 p.m. Feb. 25, 2014 - BusinessWire - BZX
Revlon Announces Executive Appointments 9:15 a.m. Feb. 25, 2014 - BusinessWire - BZX
Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation 9:02 a.m. Feb. 25, 2014 - BusinessWire - BZX
Johnson & Johnson to Participate in 2014 Cowen 34th Annual Health Care Conference 7:45 a.m. Feb. 25, 2014 - PR Newswire - PRF
Cordis Corporation Receives CE Mark for RENLANE™ Renal Denervation System to Treat Resistant Hypertension 9:59 a.m. Feb. 21, 2014 - BusinessWire - BZX
Jubilant Biosys Announces Expansion of Drug Discovery Alliance with Janssen Pharmaceutica 9:00 a.m. Feb. 19, 2014 - BusinessWire - BZX
Cordis Corporation Announces Exclusive Distribution Agreement with TriReme Medical, Inc. for the Chocolate® PTA Balloon Catheter 1:36 p.m. Feb. 18, 2014 - BusinessWire - BZX
Decision Diagnostics Announces Agreement for Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson 11:25 a.m. Feb. 18, 2014 - Marketwire
BDO USA Honored with Work-Life Seal of Distinction for 2014 10:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Two Ways to Invest in the Wireless Revolution 10:00 a.m. Feb. 18, 2014 - ACCESSWIRE
Global Laparoscopic Devices Industry 8:13 a.m. Feb. 18, 2014 - PR Newswire - PRF
Market Focus: Trends and Developments in the Skincare Sector in the US 9:00 a.m. Feb. 17, 2014 - PR Newswire - PRF
Decision Diagnostics Announces Agreement for the Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson 3:30 p.m. Feb. 14, 2014 - Marketwire
Johnson & Johnson to Participate in 2014 Citi Global Health Care Conference 7:45 a.m. Feb. 14, 2014 - PR Newswire - PRF
Diabetes - KOL Insight and Consensus Outlook Modules 10:34 a.m. Feb. 13, 2014 - PR Newswire - PRF
China Spectacles Industry Report, 2013-2015 12:46 p.m. Feb. 12, 2014 - PR Newswire - PRF
Translational Regenerative Medicine: Market Prospects 2014-2024 10:11 a.m. Feb. 12, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Critical Alerts For Johnson & Johnson, Gold SPDR, Dunkin Brands, Sears, and Macy's Released By InvestorsObserver 9:31 a.m. Feb. 12, 2014 - PR Newswire - PRF
Johnson & Johnson and Scientists Without Borders Announce Winners of Mental Health Awareness Challenge 9:00 a.m. Feb. 11, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

HelloNation Brings 'Edvertising' to NC REALTORS® Event

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Merit Expands in New York with Bold Acquisition Move

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Vitamin Angels Drives Global Nutrition Advancements

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

EMCO's New Automated Facility Could Shake Industry

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...